These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 36585757)

  • 41. Generalized pustular psoriasis and cryptogenic organizing pneumonia.
    Webber NK; Elston CM; O'Toole EA
    Br J Dermatol; 2008 Apr; 158(4):853-4. PubMed ID: 18241268
    [No Abstract]   [Full Text] [Related]  

  • 42. Polyethylene glycol: an underrecognized compound in certolizumab pegol and Movicol that may cause anaphylaxis.
    McCabe E; Tormey V; Doran JP
    Rheumatology (Oxford); 2020 Apr; 59(4):908-910. PubMed ID: 31598712
    [No Abstract]   [Full Text] [Related]  

  • 43. Exanthematic type of pustular psoriasis consisting of two types of pustular lesion.
    Matsumura N; Takematsu H; Saijo S; Hashimoto K; Tagami H
    Acta Derm Venereol; 1991; 71(5):442-4. PubMed ID: 1684477
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Psoriatic uveitis: a distinct clinical entity?
    Durrani K; Foster CS
    Am J Ophthalmol; 2005 Jan; 139(1):106-11. PubMed ID: 15652834
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long-term efficacy of certolizumab pegol for psoriasis.
    Johnson MC; Heron CE; Feldman SR
    Br J Dermatol; 2021 Apr; 184(4):588-589. PubMed ID: 32951203
    [No Abstract]   [Full Text] [Related]  

  • 46. Psoriatic arthritis and psoriasis: differential diagnosis.
    Napolitano M; Caso F; Scarpa R; Megna M; Patrì A; Balato N; Costa L
    Clin Rheumatol; 2016 Aug; 35(8):1893-1901. PubMed ID: 27156076
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comorbidities in psoriasis.
    Christophers E
    Clin Dermatol; 2007; 25(6):529-34. PubMed ID: 18021889
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Psoriatic Arthritis with Annular Pustular Psoriasis.
    Nagafuchi H; Watanabe K; Mikage H; Ozaki S
    Intern Med; 2016; 55(5):519-21. PubMed ID: 26935375
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Generalized pustular psoriasis in pregnancy, successfully treated with certolizumab pegol.
    Mizutani Y; Mizutani YH; Matsuyama K; Kawamura M; Fujii A; Shu E; Ohnishi H; Seishima M
    J Dermatol; 2020 Jul; 47(7):e262-e263. PubMed ID: 32363682
    [No Abstract]   [Full Text] [Related]  

  • 50. Psoriasiform skin eruption in a patient receiving certolizumab-pegol for ankylosing spondylitis: Report of a case and review of the literature.
    Babuna Kobaner G; Polat Ekinci A; Yilmaz Z; Copur S
    Dermatol Ther; 2018 Sep; 31(5):e12693. PubMed ID: 30225952
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Certolizumab pegol - Tumor necrosis factor inhibitor for refractory uveitis.
    Sharon Y; Chu DS
    Am J Ophthalmol Case Rep; 2020 Jun; 18():100633. PubMed ID: 32190782
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Certolizumab pegol for the treatment of psoriatic arthritis and plaque psoriasis.
    Esposito M; Carubbi F; Giunta A; Alunno A; Giacomelli R; Fargnoli MC
    Expert Rev Clin Immunol; 2020 Feb; 16(2):119-128. PubMed ID: 31917928
    [No Abstract]   [Full Text] [Related]  

  • 53. Efficacy and Safety of Certolizumab Pegol in Japanese Patients with Generalized Pustular Psoriasis and Erythrodermic Psoriasis: 52-Week Results.
    Okubo Y; Umezawa Y; Sakurai S; Hoshii N; Nakagawa H
    Dermatol Ther (Heidelb); 2022 Jun; 12(6):1397-1415. PubMed ID: 35622315
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pustular Psoriasis: A Narrative Review of Recent Developments in Pathophysiology and Therapeutic Options.
    Menter A; Van Voorhees AS; Hsu S
    Dermatol Ther (Heidelb); 2021 Dec; 11(6):1917-1929. PubMed ID: 34626330
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Successful management of infliximab-induced generalized pustular psoriasis without therapy discontinuation in a patient with psoriatic arthritis.
    Zheng J; Gao Y; Ding Y
    Dermatol Ther; 2019 Nov; 32(6):e13132. PubMed ID: 31631466
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Safety and efficacy of certolizumab pegol in a real-life cohort of patients with psoriasis and psoriatic arthritis.
    Carubbi F; Fidanza R; Palmieri M; Ventura A; Tambone S; Cipriani P; Giacomelli R; Fargnoli MC
    J Dermatolog Treat; 2020 Nov; 31(7):692-697. PubMed ID: 30963798
    [No Abstract]   [Full Text] [Related]  

  • 57. Certolizumab Pegol: A Review in Moderate to Severe Plaque Psoriasis.
    Lee A; Scott LJ
    BioDrugs; 2020 Apr; 34(2):235-244. PubMed ID: 32207094
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Successful Certolizumab Pegol Treatment of Chronic Anterior Uveitis Associated with Psoriasis Vulgaris.
    Yamaguchi K; Hayashi T; Takahashi G; Momose M; Asahina A; Nakano T
    Case Rep Ophthalmol; 2018; 9(3):499-503. PubMed ID: 30687070
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Certolizumab pegol, a pegylated anti-TNF-α antagonist, caused de novo-onset palmoplantar pustulosis followed by generalized pustular psoriasis in a patient with rheumatoid arthritis.
    Koizumi H; Tokuriki A; Oyama N; Ido H; Sugiura K; Akiyama M; Hasegawa M
    J Dermatol; 2017 Jun; 44(6):723-724. PubMed ID: 27599405
    [No Abstract]   [Full Text] [Related]  

  • 60. Recalcitrant annular pustular psoriasis associated with psoriatic arthritis successfully treated with secukinumab.
    Herrero-Moyano M; Capusan TM; Martínez-Mera C; Llamas-Velasco M; Daudén E
    JAAD Case Rep; 2018 Sep; 4(8):842-844. PubMed ID: 30246137
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.